Michael J. Morris, MD

Memorial Sloan-Kettering Cancer Center

New York, New York

Michael J. Morris, MD, is a board-certified medical oncologist who specializes in treating men with prostate cancer, particularly those who have metastatic disease or who are at high risk of developing metastatic disease. After receiving his MD from Mount Sinai School of Medicine, he completed his residency in Medicine at the Columbia Presbyterian Medical Center, as well as a fellowship in Oncology at the Memorial Sloan Kettering Cancer Center and a fellowship in Hematology at Weill Cornell Medical College.

Dr. Morris’ research interests include the study of drugs that deliver radioactive molecules targeted specifically to prostate cancer cells or to distant areas where the cancer spreads, and the development of  prostate cancer imaging using prostate-cancer-specific PET scans and other imaging methods. Additionally, he is one of the leaders of the Prostate Cancer Clinical Trials Consortium, an initiative designed to increase patient access to clinical trials across the country. Dr. Morris also serves as chair the Genitourinary Committee of the National Cancer Institute’s cooperative group Alliance for Clinical Trials in Oncology. He has filled various roles for the American Society of Clinical Oncology related to the research of prostate cancer and other genitourinary diseases. Notable awards include a mention on the annual Castle Connolly New York Magazine Top Doctors list for several years (2013, 2015-2018).